Virtu Financial LLC X4 Pharmaceuticals, Inc Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.58 - $1.47 $29,311 - $74,289	50,537 New	50,537 $29,000
Q4 2023 Feb 26, 2024	BUY	$0.61 - $0.99 $77,907 - $126,440	127,718 New	127,718 $107,000
Q2 2023 Jul 27, 2023	SELL	$0.82 - $2.49 $80,697 - $245,045	-98,412 Reduced 86.72%	15,077 $29,000
Q1 2023 May 01, 2023	BUY	$0.8 - $1.22 $90,791 - $138,456	113,489 New	113,489 $99,000
Q2 2022 Aug 09, 2022	SELL	$0.88 - $1.91 $4,910 - $10,657	-5,580 Reduced 21.49%	20,385 $20,000
Q1 2022 May 17, 2022	BUY	$1.48 - $2.58 $38,428 - $66,989	25,965 New	25,965 $45,000

103

99.9M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $54.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.